Every time I am reminded what these products can do I wonder why the company has such a low valuation.
Surely the discussions going on around the world to better prepare for the next disease or the next variant or even to better treat seasonal illnesses like flu would result in big sales of Uscom devices.
I had expected announcements by now like "Contract to equip every ICU in *insert location* with USCOM 1A". This hasnt even happened in Uscoms backyard in Australia, let alone other parts of the world. If it has, we havent been told about it.
Does anyone have any thoughts on the sales/marketing side of things? I cant see any good reason that a company with devices suited directly to treating COVID would not have risen and be continuing to rise.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.759M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 46000 | 1 |
View Market Depth
| Last trade - 16.21pm 26/06/2025 (20 minute delay) ? |
| UCM (ASX) Chart |
Day chart unavailable